Journal of Endocrinological Investigation

, Volume 3, Issue 2, pp 203–203 | Cite as

Thyroglobulin and thyrotropin-binding inhibitor immunoglobulins

  • M. C. Bridgman
  • I. B. Hales
  • B. M. Luttrell
  • J. N. Stiel
  • E. G. Wilmshurst
Letter to the Editor


Thyrotropin Thyroglobulin Multinodular Goitre Plasma Membrane Fraction Thyrotropin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Fenzi G.F., Bartalena L., Macchia E., Monzani F., Checchi M. Inteference of thyroglobulin in TSAb detection by radioreceptor assay. J. Endocrinol. Invest. 2: 221, 1979.PubMedGoogle Scholar
  2. 2.
    Van Herle A.J., Uller R.P., Mathews N.L., Brown J. Radioimmunoassay for measurement of thyroglobulin in human serum. J. Clin. Invest. 52:1320, 1973.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Hashizume K., Fenzi G.F., De Groot L.J. Thyroglobulin inhibition of thyrotropin binding to thyroid plasma membrane. J. Clin. Endocrinol. Metab. 46: 679, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Davies T.F., Yeo P.P.B., Evered D.C., Clark F., Smith B.R., Hall R. Value of thyroid-stimulating determinations in predicting short-term thyrotoxic relapse in Graves’ disease. Lancet 1: 1181, 1977.PubMedCrossRefGoogle Scholar
  5. 5.
    O’Donnell J., Trokoudes K., Silverberg J., Row V., Volpé R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves’ disease. J. Clin. Endocrinol. Metab. 46: 770, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Schleusener H., Finke R., Kotulla P., Wenzel K.W., Meinhold H., Roedler H.D. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves’ disease. A reliable indicator for the remission and persistence of this disease? J. Endocrinol. Invest. 2:155, 1978.Google Scholar
  7. 7.
    Mukhtar E.D., Smith B.R., Pyle G.A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine and antithyroid drugs. Lancet 1: 713, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Brown R., Jackson I.M.D., Pohl S.L., Reichlin S. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre? Lancet 1: 904, 1978.PubMedCrossRefGoogle Scholar
  9. 9.
    Hales I.B., Luttrell B.M., Stiel J.N., Wilmshurst E.G. The radioreceptor assay for thyroid stimulating antibodies: consideration of factors affecting specificity. Proceedings of 6th Asia and Oceania Congress of Endocrinology, Singapore, 1978, Abstract 18.Google Scholar
  10. 10.
    Ozawa Y., Maciel R.M.B., Chopra I.J., Solomon D.H., Beall G.N. Relationships among immunoglobulin markers in Graves’ disease. J. Clin. Endocrinol. Metab. 46: 734, 1978CrossRefGoogle Scholar
  11. 11.
    Endo K., Kasagi K., Konishi J., Ikekubo K., Okuno T., Takeda Y., Mori T., Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves’ disease and Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 46: 734, 1978.PubMedCrossRefGoogle Scholar
  12. 12.
    Schleusener H., Kotulla P., Finke R., Sorje H., Meinhold H., Adlkofer F., Wenzel K.W. Relationship between thyroid status and Graves’ disease specific immunoglobulins. J. Clin. Endocrinol. Metab. 47: 379, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1980

Authors and Affiliations

  • M. C. Bridgman
    • 1
  • I. B. Hales
    • 1
  • B. M. Luttrell
    • 1
  • J. N. Stiel
    • 1
  • E. G. Wilmshurst
    • 1
  1. 1.Wellcome Laboratories and Department of Nuclear Medicine and EndocrinologyRoyal North Shore HospitaL.SydneyAustralia

Personalised recommendations